Column Group Iii-a, Lp - Net Worth and Insider Trading

Column Group Iii-a, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Column Group Iii-a, Lp owns 6 companies in total, including NGM Biopharmaceuticals Inc (NGM) , Revolution Medicines Inc (RVMD) , and Constellation Pharmaceuticals Inc (CNST) among others .

Click here to see the complete history of Column Group Iii-a, Lp’s form 4 insider trades.

Insider Ownership Summary of Column Group Iii-a, Lp

Ticker Comapny Transaction Date Type of Owner
NGM NGM Biopharmaceuticals Inc 2022-01-24 10 percent owner
RVMD Revolution Medicines Inc 2020-11-16 10 percent owner
CNST Constellation Pharmaceuticals Inc 2020-03-19 10 percent owner
LIMIT LIMIT 2021-08-11 10 percent owner
LIMIT LIMIT 2022-11-21 10 percent owner
LIMIT LIMIT 2021-08-11 10 percent owner

Column Group Iii-a, Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Column Group Iii-a, Lp Ownership Network

Ownership Network List of Column Group Iii-a, Lp

No Data

Ownership Network Relation of Column Group Iii-a, Lp

Insider Network Chart

Column Group Iii-a, Lp Owned Company Details

What does NGM Biopharmaceuticals Inc do?

Who are the key executives at NGM Biopharmaceuticals Inc?

Column Group Iii-a, Lp is the 10 percent owner of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include 10 percent owner Column Group L P , director & 10 percent owner David V Goeddel , and Chief Financial Officer Jean-frederic Viret .

NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary

Over the past 18 months, Column Group Iii-a, Lp made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 67,893 shares made by Column Group L P , and a net purchase of 26,811 shares made by David V Goeddel .

In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.

NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NGM Biopharmaceuticals Inc Insider Transactions

No Available Data

Column Group Iii-a, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Column Group Iii-a, Lp. You might contact Column Group Iii-a, Lp via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.